Drug Shortage Report for OMNIPAQUE 240
Report ID | 248506 |
Drug Identification Number | 02172739 |
Brand name | OMNIPAQUE 240 |
Common or Proper name | iohexol injection USP |
Company Name | GE HEALTHCARE CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | IOHEXOL |
Strength(s) | 518MG |
Dosage form(s) | SOLUTION |
Route of administration | RECTAL ORAL INTRA-ARTICULAR INTRAVASCULAR SUBARACHNOIDAL INTRAVASCULAR SUBARACHNOIDAL |
Packaging size | 100 mL |
ATC code | V08AB |
ATC description | X-RAY CONTRAST MEDIA, IODINATED |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2025-02-13 |
Actual start date | 2025-02-12 |
Estimated end date | 2025-03-03 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-02-14 |
Company comments | Reason for shortage: production release delay. A substitute of same concentration but at a different volume will be offered as an alternative. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1919 MINNESOTA COURT MISSISSAUGA, ONTARIO CANADA L5N 0C9 |
Company contact information | 800-387-7146 canadainfo@gehealthcare.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2025-01-24 | English | Compare |
v2 | 2025-01-24 | English | Compare |
v3 | 2025-01-24 | English | Compare |
v4 | 2025-01-24 | French | Compare |
v5 | 2025-01-24 | French | Compare |
v6 | 2025-02-04 | English | Compare |
v7 | 2025-02-05 | English | Compare |
v8 | 2025-02-05 | French | Compare |
v9 | 2025-02-07 | English | Compare |
v10 | 2025-02-07 | French | Compare |
v11 | 2025-02-11 | English | Compare |
v12 | 2025-02-11 | French | Compare |
v13 | 2025-02-12 | English | Compare |
v14 | 2025-02-12 | French | Compare |
v15 | 2025-02-13 | English | Compare |
v16 | 2025-02-14 | English | Compare |
v17 | 2025-02-14 | French | Compare |
Showing 1 to 17 of 17